" class="no-js "lang="en-US"> Johan Löf - Medtech Alert
Wednesday, August 20, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Johan Löf

Johan Löf

About Johan Löf

Member of the Board of Directors of RaySearch Laboratories since 2000.

Other directorships
Chairman of Vinstandelsstiftelsen RayFoundation and Venture Cup Sweden. Several Board assignments for other companies in the RaySearch Group.

Educational background
M.Sc. in Engineering Physics from the Royal Institute of Technology and Ph.D. from the Department of Medical Radiation Physics at the Department of Oncology-Pathology, Karolinska Institutet. As a doctoral student, he worked with mathematical models for optimization of radiation therapy and also developed the prototype for ORBIT.

Professional experience
Founder of RaySearch in 2000 and President and CEO since then.

Related Story

Diseases

 RaySearch and Leo Cancer Care Join Forces to Enable Upright Radiotherapy | Pharmtech Focus

RaySearch and Leo Cancer Care Join Forces to Enable Upright Radiotherapy

September 5 2022

A key milestone and partnership for the clinical implementation of upright radiotherapy has been announced. […]

Diseases

 RayCare In Clinical Use With CyberKnife at Swiss Medical Network in Switzerland | Pharmtech Focus

RayCare In Clinical Use With CyberKnife at Swiss Medical Network in Switzerland

May 9 2022

RaySearch Laboratories AB (publ) announces that La Clinique Générale-Beaulieu, a part of Swiss Medical Network […]